{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:01:05Z","timestamp":1787029265596,"version":"build-2736575974"},"reference-count":245,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Ocular diseases including glaucoma, diabetic retinopathy and age-related macular degeneration represent a growing global health burden, with current treatments often providing only symptomatic relief. Through an integrated approach combining preclinical models, molecular biology, and clinical insights, this review synthesizes 25 years of my translational research to advance therapeutic strategies for these conditions. Key findings demonstrate the following: (1) the dual neuroprotective and intraocular pressure-lowering effects of natural compounds (EGCG, forskolin) in glaucoma models; (2) successful development of Uparant, a first-in-class peptide inhibitor of pathological angiogenesis with efficacy in retinal disease models; and (3) innovative drug delivery systems (melatonin nanomicelles, liposomal sprays) that enhance ocular bioavailability. Notably, some of these approaches have progressed to early-phase clinical trials, demonstrating translational potential. Significant challenges remain in optimizing sustained drug delivery and addressing the heterogeneity of ocular diseases through personalized approaches. Future directions include combinatorial therapies and the application of artificial intelligence for treatment optimization. Collectively, this work establishes a framework for developing multi-target therapies that address both the molecular mechanisms and clinical needs in ophthalmology.<\/jats:p>","DOI":"10.3390\/ph18060883","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T03:53:12Z","timestamp":1749786792000},"page":"883","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Personal Scientific Journey in Ophthalmology: Twenty-Five Years of Translating Research into Novel Therapies"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-2585","authenticated-orcid":false,"given":"Dario","family":"Rusciano","sequence":"first","affiliation":[{"name":"Fidia Ophthalmic Research, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"ref_1","unstructured":"WHO (2023). Blindness and Visual Impairment [Internet], World Health Organization. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Welp, A., Teutsch, S.M., McCoy, M.A., and Woodbury, R.B. (2016). Making Eye Health a Population Health Imperative: Vision for Tomorrow. The National Academies of Sciences, Engineering, and Medicine, National Academies Press (US).","DOI":"10.17226\/23471"},{"key":"ref_3","unstructured":"Wittenborn, J., and Rein, D. (2014). The Future of Vision: Forecasting the Prevalence and Costs of Vision Problems, Prevent Blindness."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Whalen, M., Akula, M., McNamee, S.M., DeAngelis, M.M., and Haider, N.B. (2024). Seeing the Future: A Review of Ocular Therapy. Bioengineering, 11.","DOI":"10.3390\/bioengineering11020179"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40266-023-01068-8","article-title":"Anti-VEGF Drugs in Age-Related Macular Degeneration: A Focus on Dosing Regimen-Related Safety and Efficacy","volume":"40","author":"Ma","year":"2023","journal-title":"Drugs Aging"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lee, H.P., Tsung, T.H., Tsai, Y.C., Chen, Y.H., and Lu, D.W. (2024). Glaucoma: Current and New Therapeutic Approaches. Biomedicines, 12.","DOI":"10.3390\/biomedicines12092000"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bachu, R.D., Chowdhury, P., Al-Saedi, Z.H.F., Karla, P.K., and Boddu, S.H.S. (2018). Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10010028"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"124899","DOI":"10.1016\/j.ijpharm.2024.124899","article-title":"Nanocarrier-Based, ocular drug delivery: Challenges, prospects, and the therapeutic landscape in the United Arab Emirates","volume":"667","author":"Mozumder","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ma, P., Pan, X., Liu, R., Qu, Y., Xie, L., Xie, J., Cao, L., and Chen, Y. (2022). Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS). Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1017889"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","article-title":"Side effects associated with prostaglandin analog therapy","volume":"53","author":"Alm","year":"2008","journal-title":"Surv. Ophthalmol."},{"key":"ref_11","first-page":"CD012208","article-title":"Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration","volume":"5","author":"Li","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100906","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ruiz-Lozano, R.E., Azar, N.S., Mousa, H.M., Quiroga-Garza, M.E., Komai, S., Wheelock-Gutierrez, L., Cartes, C., and Perez, V.L. (2023). Ocular surface disease: A known yet overlooked side effect of topical glaucoma therapy. Front. Toxicol., 5.","DOI":"10.3389\/ftox.2023.1067942"},{"key":"ref_14","unstructured":"Glaucoma Research Foundation (2025, April 05). GRF Survey Reveals Glaucoma Has Significant Impact on Patients\u2019 and Caregivers\u2019 Daily Lives, Well-Being. 5 September 2019. Available online: https:\/\/glaucoma.org\/articles\/grf-survey-reveals-glaucoma-has-significant-impact-on-patients-and-caregivers-daily-lives-well-being."},{"key":"ref_15","unstructured":"Tremain, J., and VanDyke, A. (2025, April 25). Addressing Regulatory Challenges for Ophthalmic Combination Products.  Pharmasalmanac, 28 April 2022. Available online: https:\/\/www.pharmasalmanac.com\/articles\/addressing-regulatory-challenges-for-ophthalmic-combination-products."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Giri, B.R., Jakka, D., Sandoval, M.A., Kulkarni, V.R., and Bao, Q. (2024). Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16101325"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.ophtha.2016.06.041","article-title":"Gene Therapy and Stem Cell Transplantation in Retinal Disease: The New Frontier","volume":"123","author":"MacLaren","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1017\/erm.2024.4","article-title":"AAV-mediated gene therapies for glaucoma and uveitis: Are we there yet?","volume":"26","author":"Castro","year":"2024","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_19","unstructured":"Kesharwani, P. (2022). Combination drug delivery approaches in ophthalmology. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases, Academic Press."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Jin, K., and Zhang, C. (2023). Personalized Medicine in Ophthalmic Diseases: Challenges and Opportunities. J. Pers. Med., 13.","DOI":"10.3390\/books978-3-0365-8021-0"},{"key":"ref_21","first-page":"17","article-title":"Hormones and eye diseases","volume":"1","author":"Rusciano","year":"2016","journal-title":"J. Clin. Mol. Endocrinol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Traish, A., and Douglas, V.P. (2023). Ocular Surface Anatomy and Physiology. Pediatric Ocular Surface Disease, Springer.","DOI":"10.1007\/978-3-031-30562-7"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ali\u00f3, J., Ali\u00f3 del Barrio, J., and Arnalich-Montiel, F. (2019). Ocular Surface Epithelium: Applied Anatomy. Corneal Regeneration, Springer. Part of the Book Series: Essentials in Ophthalmology.","DOI":"10.1007\/978-3-030-01304-2"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Dolar-Szczasny, J., Toro, M.D., Dworza\u0144ska, A., W\u00f3jtowicz, T., Korona-Glowniak, I., Sawicki, R., Boguszewska, A., Polz-Dacewicz, M., Tomasiewicz, K., and Za\u0142uska, W. (2021). Ocular Involvement of SARS-CoV-2 in a Polish Cohort of COVID-19-Positive Patients. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18062916"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4172\/2155-9570.1000417","article-title":"Neovascularization in Alkali-Burned Rabbit Cornea","volume":"6","author":"Pescosolido","year":"2015","journal-title":"J. Clin. Exp. Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lasagni Vitar, R.M., Triolo, G., Fonteyne, P., Acuti Martellucci, C., Manzoli, L., Rama, P., and Ferrari, G. (2021). Epidemiology of Corneal Neovascularization and Its Impact on Visual Acuity and Sensitivity: A 14-Year Retrospective Study. Front. Med., 8.","DOI":"10.3389\/fmed.2021.733538"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tice.2004.05.003","article-title":"Cytokeratin expression in primary epithelial cell culture from bovine conjunctiva","volume":"36","author":"Paladino","year":"2004","journal-title":"Tissue Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000087372","article-title":"Lactoferrin expression by bovine ocular surface epithelia: A primary cell culture model to study lactoferrin gene promoter activity","volume":"37","author":"Santagati","year":"2005","journal-title":"Ophthalmic Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Regueiro, U., L\u00f3pez-L\u00f3pez, M., Varela-Fern\u00e1ndez, R., Otero-Espinar, F.J., and Lema, I. (2023). Biomedical Applications of Lactoferrin on the Ocular Surface. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030865"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/BF02624618","article-title":"Ultrastructural and immunohistological characterization of the SIRC corneal cell line","volume":"26","author":"Niederkorn","year":"1990","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/15569527.2017.1347942","article-title":"N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: An in vitro comparative study","volume":"37","author":"Cristaldi","year":"2018","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/ICO.0000000000001594","article-title":"Experimental Evidence of the Healing Properties of Lactobionic Acid for Ocular Surface Disease","volume":"37","author":"Olivieri","year":"2018","journal-title":"Cornea"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/ICO.0000000000002357","article-title":"Isolation and Characterization of a New Human Corneal Epithelial Cell Line: HCE-F","volume":"39","author":"Cristaldi","year":"2020","journal-title":"Cornea"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.30564\/jim.v10i2.3382","article-title":"An Association of Vitamins A and E with Hyaluronic and Lactobionic Acids may Prevent Molecular Changes Associated with Keratocyte to Myofibroblast Transition","volume":"10","author":"Cristaldi","year":"2021","journal-title":"J. Integr. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40123-022-00458-2","article-title":"Cosmetic Change of the Apparent Color of the Eye: A Review on Surgical Alternatives, Outcomes and Complications","volume":"11","author":"Alio","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Queiruga-Pi\u00f1eiro, J., Parra-Rodriguez, T., and Rodriguez-Una, I. (2022). Long-term complications of cosmetic iris implants. BMC Ophthalmol., 22, Erratum in BMC Ophthalmol. 2023, 23, 8.","DOI":"10.1186\/s12886-022-02650-1"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s10792-023-02700-7","article-title":"Intrastromal keratopigmentation: A boon for unsightly corneal scars","volume":"43","author":"Mohan","year":"2023","journal-title":"Int. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3892\/ijmm.2017.3104","article-title":"Melanogenesis in uveal melanoma cells: Effect of argan oil","volume":"40","author":"Caporarello","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ajo.2010.11.003","article-title":"Amino Acid profiles in human tear fluids analyzed by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry","volume":"151","author":"Nakatsukasa","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2016.04.029","article-title":"Free amino acids: An innovative treatment for ocular surface disease","volume":"787","author":"Rusciano","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.febslet.2006.03.028","article-title":"Oxidized protein degradation and repair in ageing and oxidative stress","volume":"580","author":"Friguet","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1515\/bmc-2012-0001","article-title":"The role of hyperosmotic stress in inflammation and disease","volume":"3","author":"Brocker","year":"2012","journal-title":"Biomol. Concepts"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S374","DOI":"10.3928\/1081-597X-20020502-20","article-title":"Use of amino acids in refractive surgery","volume":"18","author":"Vinciguerra","year":"2002","journal-title":"J. Refract. Surg."},{"key":"ref_45","first-page":"S227","article-title":"The role of amino acids in corneal stromal healing: A method for evaluating cellular density and extracellular matrix distribution","volume":"19","author":"Grizzi","year":"2003","journal-title":"J. Refract. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Roszkowska, A.M., Rusciano, D., Inferrera, L., Severo, A.A., and Aragona, P. (2021). Oral Aminoacids Supplementation Improves Corneal Reinnervation After Photorefractive Keratectomy: A Confocal-Based Investigation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.680734"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Pellegrini, M., Senni, C., Bernabei, F., Cicero, A.F.G., Vagge, A., Maestri, A., Scorcia, V., and Giannaccare, G. (2020). The Role of Nutrition and Nutritional Supplements in Ocular Surface Diseases. Nutrients, 12.","DOI":"10.3390\/nu12040952"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1111\/aos.12134","article-title":"Effects of amino acids enriched tears substitutes on the cornea of patients with dysfunctional tear syndrome","volume":"91","author":"Aragona","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-2004-813715","article-title":"Ein neues Therapiekonzept zur Behandlung des Trockenen Auges\u2014Die Verwendung von Phospholipid-Liposomen [A new therapy concept for the treatment of dry eye\u2014The usefulness of phospholipid liposomes]","volume":"221","author":"Lee","year":"2004","journal-title":"Klin. Monbl Augenheilkd."},{"key":"ref_50","unstructured":"Modugno, R.L., Feuerman, O.M., La Gloria Valerio, A., Scalora, T., Salami, E., and Leonardi, A. (2021). A Novel Liposome-Based, Aminoacid- and Vitamin-Containing Tear Substitute in Patients with Evaporative Dry Eye Disease. J. Community Med. Public Health Rep., 2."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clae.2009.12.007","article-title":"Effect of a liposomal spray on the pre-ocular tear film","volume":"33","author":"Craig","year":"2010","journal-title":"Cont. Lens Anterior Eye"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0028-1109686","article-title":"Vergleichende Untersuchung zur Therapie des evaporativen trockenen Auges [Comparative investigation of treatments for evaporative dry eye]","volume":"227","author":"Khaireddin","year":"2010","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_53","first-page":"97","article-title":"Short-term efficacy of two lipidic eyedrops in the treatment of evaporative dry eye","volume":"2","author":"Fogagnolo","year":"2016","journal-title":"Ital. Rev. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000489093","article-title":"Age-Related Dry Eye Lactoferrin and Lactobionic Acid","volume":"60","author":"Rusciano","year":"2018","journal-title":"Ophthalmic Res."},{"key":"ref_55","first-page":"102","article-title":"Age-related differential efficacy on dry eye of lactobionic acid-based eye drops","volume":"7","author":"Gagliano","year":"2018","journal-title":"Paripex Indian J. Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ramasubramanian, D., Hern\u00e1ndez-Verdejo, J.L., and L\u00f3pez-Alonso, J.M. (2025). Influence of Contact Lens Parameters on Tear Film Dynamics. Bull. Math. Biol., 87.","DOI":"10.1007\/s11538-025-01425-1"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Nagai, N., Sakurai, S., Seiriki, R., Minami, M., Yamaguchi, M., Deguchi, S., and Harata, E. (2021). MPC Polymer Promotes Recovery from Dry Eye via Stabilization of the Ocular Surface. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020168"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/OPX.0000000000001642","article-title":"Poly 2-methacryloyloxyethyl Phosphorylcholine Protects Corneal Cells and Contact Lenses from Desiccation Damage","volume":"98","author":"Olivieri","year":"2021","journal-title":"Optom. Vis. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Gagliano, C., Zeppieri, M., Longo, A., Rubegni, G., Amato, R., Foti, R., Cappellani, F., Cocuzza, M., Visalli, F., and Cannizzaro, L. (2024). Efficacy and Safety of Artificial Tears Containing Lipidure and Hypromellose for the Treatment of Moderate Dry Eye Disease in Contact Lens Wearers. Medicina, 60.","DOI":"10.3390\/medicina60020287"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Albert, D.M., Miller, J.W., Azar, D.T., and Young, L.H. (2022). Glaucoma Filtration Surgery: Indications, Techniques, and Complications. Albert and Jakobiec\u2019s Principles and Practice of Ophthalmology, Springer.","DOI":"10.1007\/978-3-030-42634-7"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10384-024-01142-7","article-title":"Three-year outcomes of surgical bleb revision with mitomycin C for early scarring bleb after trabeculectomy","volume":"69","author":"Sakamoto","year":"2025","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Minnelli, C., Piva, F., Cecati, M., Armeni, T., Mobbili, G., Galeazzi, R., Melecchi, A., Cristaldi, M., Corsaro, R., and Rusciano, D. (2023). Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma. Pharmaceuticals, 16.","DOI":"10.3390\/ph16040594"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Papachristoforou, N., Ueno, A., Ledwos, K., Bartu\u015b, J., Nowi\u0144ska, A., and Karska-Basta, I. (2025). A Review of Keratoconus Cross-Linking Treatment Methods. J. Clin. Med., 14.","DOI":"10.3390\/jcm14051702"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1167\/iovs.16-20813","article-title":"Biomechanical Strengthening of the Human Cornea Induced by Nanoplatform-Based Transepithelial Riboflavin\/UV-A Corneal Cross-Linking","volume":"58","author":"Labate","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcrs.2017.03.026","article-title":"Assessment of stromal riboflavin concentration-depth profile in nanotechnology-based transepithelial corneal crosslinking","volume":"43","author":"Lombardo","year":"2017","journal-title":"J. Cataract. Refract. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Lombardo, G., Bernava, G.M., Serrao, S., and Lombardo, M. (2022). Theranostic-guided corneal cross-linking: Preclinical evidence on a new treatment paradigm for keratoconus. J. Biophotonics, 15.","DOI":"10.1002\/jbio.202200218"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.ophtha.2024.06.012","article-title":"Assessment of the Predictive Ability of Theranostics for Corneal Cross-linking in Treating Keratoconus: A Randomized Clinical Trial","volume":"131","author":"Roszkowska","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Rusciano, D., Bagnoli, P., Gallar, J., and Galor, A. (2022). Editorial: Eye Pain: Etiology and Therapeutic Approaches. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.914809"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2058738419838383","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: An overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli","year":"2019","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Rusciano, D. (2024). Molecular Mechanisms and Therapeutic Potential of Gabapentin with a Focus on Topical Formulations to Treat Ocular Surface Diseases. Pharmaceuticals, 17.","DOI":"10.20944\/preprints202404.1936.v1"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Cammalleri, M., Amato, R., Olivieri, M., Pezzino, S., Bagnoli, P., Dal Monte, M., and Rusciano, D. (2021). Effects of Topical Gabapentin on Ocular Pain and Tear Secretion. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.671238"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Anfuso, C.D., Olivieri, M., Fidilio, A., Lupo, G., Rusciano, D., Pezzino, S., Gagliano, C., Drago, F., and Bucolo, C. (2017). Gabapentin Attenuates Ocular Inflammation: In vitro and In vivo Studies. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00173"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Gagliano, C., Salvetat, M.L., Musa, M., D\u2019Esposito, F., Rusciano, D., Maniaci, A., Pellegrini, F., Scibilia, G., and Zeppieri, M. (2024). Bacterial Insights: Unraveling the Ocular Microbiome in Glaucoma Pathogenesis. Front. Biosci., 29.","DOI":"10.31083\/j.fbl2908310"},{"key":"ref_74","unstructured":"Rusciano, D. (2025). Restoring Ocular Microbiota Balance: A New Bioprinted Approach to Treating Anterior Segment Diseases. Front. Biosci. (Landmark Ed.), in press."},{"key":"ref_75","first-page":"19598","article-title":"Dexamethasone Improves Ofloxacin Efficacy in Treating Acute Bacterial Conjunctivitis: Evidence from A Rabbit Model","volume":"26","author":"Tavanti","year":"2020","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Sarkis, S., Chamard, C., Johansen, B., Daien, V., and Michon, F. (2025). Challenging glaucoma with emerging therapies: An overview of advancements against the silent thief of sight. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1527319"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/01913123.2011.634090","article-title":"Trabecular meshwork in normal and pathological eyes","volume":"36","author":"Pescosolido","year":"2012","journal-title":"Ultrastruct. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"101303","DOI":"10.1016\/j.preteyeres.2024.101303","article-title":"The relationship between intraocular pressure and glaucoma: An evolving concept","volume":"103","author":"Asrani","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3076031","DOI":"10.1155\/2016\/3076031","article-title":"Relationship between Corneal Temperature and Intraocular Pressure in Healthy Individuals: A Clinical Thermographic Analysis","volume":"2016","author":"Fabiani","year":"2016","journal-title":"J. Ophthalmol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Grosso, A., Borrelli, E., Sacchi, M., Calzetti, G., Ceruti, P., Neri, G., Marchetti, M., Pinna, A., Kostin, V., and Reibaldi, M. (2025). Neuroprotection beyond intraocular pressure: Game changer or quiet addiction. Graefe\u2019s Arch. Clin. Exp. Ophthalmol.","DOI":"10.1007\/s00417-025-06816-7"},{"key":"ref_81","first-page":"4320408","article-title":"Neuroprotection in Glaucoma: Old and New Promising Treatments","volume":"2017","author":"Rusciano","year":"2017","journal-title":"Adv. Pharmacol. Sci."},{"key":"ref_82","first-page":"00024","article-title":"Critical Review on the Relationship between Glaucoma and Alzheimer\u2019s Disease","volume":"1","author":"Pescosolido","year":"2014","journal-title":"Adv. Ophthalmol. Vis. Syst."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2007.05.029","article-title":"Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia\/reperfusion","volume":"1159","author":"Zhang","year":"2007","journal-title":"Brain Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2007.12.015","article-title":"Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro","volume":"1198","author":"Zhang","year":"2008","journal-title":"Brain Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3892\/etm.2021.10669","article-title":"Neuroprotective role of epigallocatechin-3-gallate in acute glaucoma via the nuclear factor-\u03baB signalling pathway","volume":"22","author":"Zhang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"747","DOI":"10.18240\/ijo.2022.05.09","article-title":"Green tea-a new perspective of glaucoma prevention","volume":"15","author":"Gasiunas","year":"2022","journal-title":"Int. J. Ophthalmol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00417-009-1064-z","article-title":"Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: A short-term study by pattern electroretinogram","volume":"247","author":"Falsini","year":"2009","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2015.06.002","article-title":"Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma","volume":"600","author":"Shen","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"108447","DOI":"10.1016\/j.exer.2021.108447","article-title":"Epigallocatechin-3-gallate increases autophagic activity attenuating TGF-\u03b21-induced transformation of human Tenon\u2019s fibroblasts","volume":"204","author":"Zhang","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7435754","DOI":"10.1155\/2022\/7435754","article-title":"Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress","volume":"2022","author":"Zhou","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/AAC.48.6.1968-1973.2004","article-title":"Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells","volume":"48","author":"Blanco","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"113596","DOI":"10.1016\/j.jconrel.2025.113596","article-title":"Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma","volume":"381","author":"Pan","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.colsurfb.2014.09.042","article-title":"Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation","volume":"123","author":"Fangueiro","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0022-3859.101396","article-title":"Forskolin: Upcoming antiglaucoma molecule","volume":"58","author":"Wagh","year":"2012","journal-title":"J. Postgrad. Med."},{"key":"ref_95","first-page":"268","article-title":"Forskolin lowers intraocular pressure by reducing aqueous inflow","volume":"25","author":"Caprioli","year":"1984","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-2007-969566","article-title":"Forskolin: From an ayurvedic remedy to a modern agent","volume":"51","author":"Ammon","year":"1985","journal-title":"Planta Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Lamas, N.J., Johnson-Kerner, B., Roybon, L., Kim, Y.A., Garcia-Diaz, A., Wichterle, H., and Henderson, C.E. (2014). Neurotrophic requirements of human motor neurons defined using amplified and purified stem cell-derived cultures. PLoS ONE, 9, Erratum in PLoS ONE 2015, 10, e0119195.","DOI":"10.1371\/journal.pone.0110324"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbrc.2012.12.122","article-title":"Upregulation of TrkB by forskolin facilitated survival of MSC and functional recovery of memory deficient model rats","volume":"431","author":"Heo","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_99","unstructured":"Walker, M.H. (2015). Oral administration of forskolin decreases retinal damage after experimental induction of ocular hypertension in the rat. Forskolin, Nova Science Publishers, Inc.. 978-1-63463-918-7."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1089\/jop.2012.0021","article-title":"Oral administration of forskolin and rutin contributes to intraocular pressure control in primary open angle glaucoma patients under maximum tolerated medical therapy","volume":"28","author":"Vetrugno","year":"2012","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_101","unstructured":"Sisto, D., Lavermicocca, N., Errico, D., and Rusciano, D. (2014). Oral Administration of Forskolin and Rutin Contributes to Reduce Intraocular Pressure and Improve PERG (Pattern Electroretinogram) Amplitude in Glaucomatous Patients. JSM Biotechnol. Bioeng., 2, Available online: https:\/\/www.jscimedcentral.com\/public\/assets\/articles\/biotechnology-2-1036.pdf."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Rusciano, D. (2024). Health Benefits of Epigallocatechin Gallate and Forskolin with a Special Emphasis on Glaucoma and Other Retinal Diseases. Medicina, 60.","DOI":"10.20944\/preprints202410.1335.v1"},{"key":"ref_103","first-page":"718","article-title":"Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury","volume":"21","author":"Russo","year":"2015","journal-title":"Mol. Vis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/jop.2015.0121","article-title":"Oral Administration of Forskolin, Homotaurine, Carnosine, and Folic Acid in Patients with Primary Open Angle Glaucoma: Changes in Intraocular Pressure, Pattern Electroretinogram Amplitude, and Foveal Sensitivity","volume":"32","author":"Mutolo","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Locri, F., Cammalleri, M., Dal Monte, M., Rusciano, D., and Bagnoli, P. (2019). Protective Efficacy of a Dietary Supplement Based on Forskolin, Homotaurine, Spearmint Extract, and Group B Vitamins in a Mouse Model of Optic Nerve Injury. Nutrients, 11.","DOI":"10.3390\/nu11122931"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Cammalleri, M., Dal Monte, M., Amato, R., Bagnoli, P., and Rusciano, D. (2020). A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma. Nutrients, 12.","DOI":"10.3390\/nu12041189"},{"key":"ref_107","first-page":"77","article-title":"Forskolin and rutin prevent intraocular pressure spikes after Nd:YAG laser iridotomy","volume":"54","author":"Nebbioso","year":"2012","journal-title":"Panminerva Med."},{"key":"ref_108","first-page":"3611","article-title":"Preparation and characterization of ophthalmic in situ forming gels containing forskolin","volume":"8","author":"Pignatello","year":"2018","journal-title":"Biointerface Res. Appl. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Gandolfi, S., Marchini, G., Caporossi, A., Scuderi, G., Tomasso, L., and Brunoro, A. (2020). Cytidine 5\u2032-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma. Nutrients, 12.","DOI":"10.3390\/nu12030793"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/IJG.0000000000001565","article-title":"Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial","volume":"29","author":"Rossetti","year":"2020","journal-title":"J. Glaucoma"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00417-022-05947-5","article-title":"The effect of citicoline oral solution on quality of life in patients with glaucoma: The results of an international, multicenter, randomized, placebo-controlled cross-over trial","volume":"261","author":"Rossetti","year":"2023","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1089\/jop.2021.0018","article-title":"Neuroprotective Effects of Citicoline on Methanol-Intoxicated Retina Model in Rats","volume":"37","author":"Laksmita","year":"2021","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.exer.2006.05.021","article-title":"Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat","volume":"83","author":"Schuettauf","year":"2006","journal-title":"Exp. Eye Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e644","DOI":"10.1016\/j.wneu.2023.06.117","article-title":"Neuroprotective Effects of Niacin on Ischemia\/Reperfusion Injury of the Rabbit Spinal Cord","volume":"177","author":"Ermutlu","year":"2023","journal-title":"World Neurosurg."},{"key":"ref_115","first-page":"1028","article-title":"Anti-Inflammatory, Antioxidant and Neuroprotective Effects of Niacin on Mild Traumatic Brain Injury in Rats","volume":"33","author":"Ozaydin","year":"2023","journal-title":"Turk. Neurosurg."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Gemae, M.R., Bassi, M.D., Wang, P., Chin, E.K., and Almeida, D.R.P. (2024). NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review. Nutrients, 16.","DOI":"10.3390\/nu16162795"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"263786","DOI":"10.1155\/2014\/263786","article-title":"Niacin inhibits vascular inflammation via downregulating nuclear transcription factor-\u03baB signaling pathway","volume":"2014","author":"Si","year":"2014","journal-title":"Mediators Inflamm."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Melecchi, A., Amato, R., Dal Monte, M., Rusciano, D., Bagnoli, P., and Cammalleri, M. (2023). Restored retinal physiology after administration of niacin with citicoline in a mouse model of hypertensive glaucoma. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1230941"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"La Rosa, L.R., Pepe, V., Lazzara, F., Romano, G.L., Conti, F., Giuffrida, E., Bucolo, C., Viola, S., De Pasquale, G., and Curatolo, M.C. (2025). Retinal Protection of New Nutraceutical Formulation. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17010073"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/opo.12189","article-title":"Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients","volume":"35","author":"Pescosolido","year":"2015","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Dal Monte, M., Cammalleri, M., Pezzino, S., Corsaro, R., Pescosolido, N., Bagnoli, P., and Rusciano, D. (2020). Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy. Diagnostics, 10.","DOI":"10.3390\/diagnostics10030138"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Dal Monte, M., Cammalleri, M., Amato, R., Pezzino, S., Corsaro, R., Bagnoli, P., and Rusciano, D. (2020). A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239267"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Rusciano, D., and Russo, C. (2024). The Therapeutic Trip of Melatonin Eye Drops: From the Ocular Surface to the Retina. Pharmaceuticals, 17.","DOI":"10.20944\/preprints202403.0327.v1"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21037\/aes-2022-1","article-title":"Preclinical models in ophthalmic research","volume":"7","author":"Rusciano","year":"2022","journal-title":"Ann. Eye Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_126","first-page":"1022","article-title":"Diabetic Retinopathy and Hypertension","volume":"3","author":"Pescosolido","year":"2015","journal-title":"Ann. Clin. Exp. Hypertens."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4239\/wjd.v4.i6.290","article-title":"Classification of diabetic retinopathy and diabetic macular edema","volume":"4","author":"Wu","year":"2013","journal-title":"World J. Diabetes"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e2021053924","DOI":"10.1542\/peds.2021-053924","article-title":"Retinopathy of Prematurity: A Global Perspective and Recent Developments","volume":"150","author":"Sabri","year":"2022","journal-title":"Pediatrics"},{"key":"ref_129","unstructured":"Pescosolido, N., Fazio, S., and Rusciano, D. (2014). Reliability of the Implicit Time of Flicker ERG B-Wave as an Objective Diagnostic Tool for Retinopathies. JSM Biotechnol. Bioeng., 2."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Rusciano, D., and Marsili, S. (2025). Editorial to the Special Issue \u201cRetinopathies: A Challenge for Early Diagnosis, Innovative Treatments, and Reliable Follow-Up\u201d. Medicina, 61.","DOI":"10.3390\/medicina61040662"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/08820538.2022.2152706","article-title":"Molecular Mediators and Regulators of Retinal Angiogenesis","volume":"38","author":"Vishwakarma","year":"2023","journal-title":"Semin. Ophthalmol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Rusciano, D., and Bagnoli, P. (2023). Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases. Medicina, 59.","DOI":"10.3390\/medicina59071334"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.febslet.2008.03.001","article-title":"An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor","volume":"582","author":"Bifulco","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1538-7836.2010.04075.x","article-title":"The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence","volume":"8","author":"Bifulco","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Bifulco, K., Longanesi-Cattani, I., Franco, P., Pavone, V., Mugione, P., Di Carluccio, G., Masucci, M.T., Arra, C., Pirozzi, G., and Stoppelli, M.P. (2012). Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044806"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1158\/1535-7163.MCT-13-0077","article-title":"A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting","volume":"12","author":"Bifulco","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/1535-7163.MCT-13-0949","article-title":"UPARANT: A urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency","volume":"13","author":"Carriero","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1167\/iovs.16-19909","article-title":"Molecular Mechanisms Mediating Antiangiogenic Action of the Urokinase Receptor-Derived Peptide UPARANT in Human Retinal Endothelial Cells","volume":"57","author":"Motta","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1167\/iovs.14-16323","article-title":"Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy","volume":"56","author":"Rezzola","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1167\/iovs.15-18758","article-title":"The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization","volume":"57","author":"Cammalleri","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2904150","DOI":"10.1155\/2017\/2904150","article-title":"Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System","volume":"2017","author":"Cammalleri","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1167\/iovs.17-21593","article-title":"The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood-Retinal Barrier Leakage in a Rat Model of Diabetes","volume":"58","author":"Cammalleri","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00125-016-4204-0","article-title":"Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy","volume":"60","author":"Rezzola","year":"2017","journal-title":"Diabetologia"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Cammalleri, M., Dal Monte, M., Pavone, V., De Rosa, M., Rusciano, D., and Bagnoli, P. (2019). The uPAR System as a Potential Therapeutic Target in the Diseased Eye. Cells, 8.","DOI":"10.3390\/cells8080925"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1111\/jcmm.14391","article-title":"The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model","volume":"23","author":"Cammalleri","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Cammalleri, M., Dal Monte, M., Locri, F., Lardner, E., Kvanta, A., Rusciano, D., Andr\u00e9, H., and Bagnoli, P. (2017). Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration. Nutrients, 9.","DOI":"10.3390\/nu9101079"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Locri, F., Cammalleri, M., Pini, A., Dal Monte, M., Rusciano, D., and Bagnoli, P. (2018). Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis. Nutrients, 10.","DOI":"10.3390\/nu10101447"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Dal Monte, M., Cammalleri, M., Locri, F., Amato, R., Marsili, S., Rusciano, D., and Bagnoli, P. (2018). Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis. Nutrients, 10.","DOI":"10.3390\/nu10030325"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Anfuso, C.D., Giurdanella, G., Longo, A., Cosentino, A., Agafonova, A., Rusciano, D., and Lupo, G. (2022). Antioxidant Activity of Cyanidin-3-O-Glucoside and Verbascoside in an in Vitro Model of Diabetic Retinopathy. Front. Biosci., 27.","DOI":"10.31083\/j.fbl2711308"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Cristaldi, M., Anfuso, C.D., Spampinato, G., Rusciano, D., and Lupo, G. (2022). Comparative Efficiency of Lutein and Astaxanthin in the Protection of Human Corneal Epithelial Cells In Vitro from Blue-Violet Light Photo-Oxidative Damage. Appl. Sci., 12.","DOI":"10.3390\/app12031268"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Amato, R., Canovai, A., Melecchi, A., Pezzino, S., Corsaro, R., Dal Monte, M., Rusciano, D., Bagnoli, P., and Cammalleri, M. (2021). Dietary Supplementation of Antioxidant Compounds Prevents Light-Induced Retinal Damage in a Rat Model. Biomedicines, 9.","DOI":"10.3390\/biomedicines9091177"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Canovai, A., Amato, R., Melecchi, A., Dal Monte, M., Rusciano, D., Bagnoli, P., and Cammalleri, M. (2022). Preventive Efficacy of an Antioxidant Compound on Blood Retinal Barrier Breakdown and Visual Dysfunction in Streptozotocin-Induced Diabetic Rats. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.811818"},{"key":"ref_153","first-page":"1","article-title":"Efficacy of a New Antioxidants Blend in Protecting RPE Cells in vitro and in Improving the Visual Performance of Sport Pilots","volume":"4","author":"Filippello","year":"2021","journal-title":"Ophthalmol. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.7150\/ijbs.49890","article-title":"The Role of Inflammation in Age-Related Macular Degeneration","volume":"16","author":"Tan","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/JIR.S347231","article-title":"Long-Chain Polyunsaturated Fatty Acids and Their Metabolites Regulate Inflammation in Age-Related Macular Degeneration","volume":"15","author":"Ren","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Mezouar, S., and Mege, J.L. (2024). Macrophages: Molecular pathways and immunometabolic processes. Macrophages\u2014Molecular Pathways and Immunometabolic Processes, IntechOpen.","DOI":"10.5772\/intechopen.1000415"},{"key":"ref_158","first-page":"1796","article-title":"Macrophage fatty acid oxidation and its roles in macrophage polarization and fatty acid-induced inflammation","volume":"1861","author":"Namgaladze","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jama.2015.9677","article-title":"Age-Related Eye Disease Study 2 (AREDS2) Research Group Effect of Omega-3 Fatty Acids Lutein\/Zeaxanthin or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial","volume":"314","author":"Chew","year":"2015","journal-title":"JAMA"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Melecchi, A., Amato, R., Lapi, D., Dal Monte, M., Rusciano, D., Bagnoli, P., and Cammalleri, M. (2022). Increased efficacy of dietary supplement containing wax ester-rich marine oil and xanthophylls in a mouse model of dry macular degeneration. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1038730"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"104148","DOI":"10.1016\/j.jff.2020.104148","article-title":"Cyanidin-3-glucoside protects liver from oxidative damage through AMPK\/Nrf2 mediated signaling pathway in vivo and in vitro","volume":"73","author":"Yu","year":"2020","journal-title":"J. Funct. Foods."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/abbi.2000.2171","article-title":"Lutein, zeaxanthin, and the macular pigment","volume":"385","author":"Landrum","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Giannaccare, G., Pellegrini, M., Senni, C., Bernabei, F., Scorcia, V., and Cicero, A.F.G. (2020). Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights. Mar. Drugs, 18.","DOI":"10.3390\/md18050239"},{"key":"ref_164","first-page":"83","article-title":"The effect of night vision goggles on the retinocortical bioelectrical activity and its improvement by food supplement","volume":"54","author":"Pescosolido","year":"2012","journal-title":"Panminerva Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2174\/1570159X14666160321122900","article-title":"Autophagy in Diabetic Retinopathy","volume":"14","author":"Gagliano","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_166","first-page":"57","article-title":"Leber\u2019s hereditary optic neuropathy\u2014Current status of idebenone and gene replacement therapies","volume":"37","author":"Klopstock","year":"2025","journal-title":"Med. Genet."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Minnelli, C., Laudadio, E., Galeazzi, R., Rusciano, D., Armeni, T., Stipa, P., Cantarini, M., and Mobbili, G. (2019). Synthesis, Characterization and Antioxidant Properties of a New Lipophilic Derivative of Edaravone. Antioxidants, 8.","DOI":"10.3390\/antiox8080258"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Minnelli, C., Laudadio, E., Fiorini, R., Galeazzi, R., Armeni, T., Stipa, P., Rusciano, D., and Mobbili, G. (2022). Influence of a lipophilic edaravone on physical state and activity of antioxidant liposomes: An experimental and in silico study. Colloids Surf. B Biointerfaces, 210.","DOI":"10.1016\/j.colsurfb.2021.112217"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1039\/D2OB01143C","article-title":"Salt effects on mixed composition membranes containing an antioxidant lipophilic edaravone derivative: A computational-experimental study","volume":"20","author":"Laudadio","year":"2022","journal-title":"Org. Biomol. Chem."},{"key":"ref_170","unstructured":"(2019). World Report on Vision, World Health Organization. Available online: https:\/\/www.who.int\/Publications\/i\/Item\/9789241516570."},{"key":"ref_171","unstructured":"GBD 2019 Blindness and Vision Impairment Collaborators (2021). Trends in prevalence of blindness and distance and near vision impairment over 30 years. Lancet Glob. Health, 9, e130\u2013e143."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.ophtha.2018.04.013","article-title":"Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling","volume":"125","author":"Fricke","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ophtha.2018.10.029","article-title":"Potential Lost Productivity Resulting from the Global Burden of Myopia: Systematic Review, Meta-analysis, and Modeling","volume":"126","author":"Naidoo","year":"2019","journal-title":"Ophthalmology"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/09286586.2021.1954664","article-title":"Refractive Error Findings in Students Who Failed School-based Vision Screening","volume":"29","author":"Guo","year":"2022","journal-title":"Ophthalmic Epidemiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jdeveco.2016.05.007","article-title":"A better vision for development: Eyeglasses and academic performance in rural primary schools in China","volume":"122","author":"Glewwe","year":"2016","journal-title":"J. Dev. Econ."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/j.jcjo.2022.11.019","article-title":"Effect of visual impairment on depression and anxiety during the COVID-19 pandemic in the United States","volume":"59","author":"Sekimitsu","year":"2024","journal-title":"Can. J. Ophthalmol."},{"key":"ref_178","first-page":"91","article-title":"School vision screening programmes in reducing uncorrected refractive error among children in Low and Middle-Income countries-LMIC: A systematic review","volume":"10","author":"Opare","year":"2020","journal-title":"Eye Vis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000501937","article-title":"Significance of Outdoor Time for Myopia Prevention: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials","volume":"63","author":"Cao","year":"2020","journal-title":"Ophthalmic Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/eye.2013.254","article-title":"Genetic and environmental effects on myopia development and progression","volume":"28","author":"Goldschmidt","year":"2014","journal-title":"Eye"},{"key":"ref_181","first-page":"116","article-title":"Childhood myopia: Epidemiology, risk factors, and prevention","volume":"112","author":"Recko","year":"2015","journal-title":"Mo. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.aopr.2024.06.003","article-title":"Complications of high myopia: An update from clinical manifestations to underlying mechanisms","volume":"4","author":"Du","year":"2024","journal-title":"Adv. Ophthalmol. Pract. Res."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Tariq, F., Mobeen, R., Wang, X., Lin, X., Bao, Q., Liu, J., and Gao, H. (2023). Advances in myopia prevention strategies for school-aged children: A comprehensive review. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1226438"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1004977","DOI":"10.1155\/2022\/1004977","article-title":"Myopia: Mechanisms and Strategies to Slow Down Its Progression","volume":"2022","author":"Russo","year":"2022","journal-title":"J. Ophthalmol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.aopr.2024.06.001","article-title":"Animal modeling for myopia","volume":"4","author":"Zheng","year":"2024","journal-title":"Adv. Ophthalmol. Pract. Res."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Chierigo, A., Ferro Desideri, L., Traverso, C.E., and Vagge, A. (2022). The Role of Atropine in Preventing Myopia Progression: An Update. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14050900"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.4103\/ijo.IJO_2415_21","article-title":"Myopia, its prevalence, current therapeutic strategy and recent developments: A Review","volume":"70","author":"Singh","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.pmbts.2015.05.005","article-title":"Scleral Mechanisms Underlying Ocular Growth and Myopia","volume":"134","author":"Metlapally","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Cristaldi, M., Olivieri, M., Pezzino, S., Spampinato, G., Lupo, G., Anfuso, C.D., and Rusciano, D. (2020). Atropine Differentially Modulates ECM Production by Ocular Fibroblasts, and Its Ocular Surface Toxicity Is Blunted by Colostrum. Biomedicines, 8.","DOI":"10.3390\/biomedicines8040078"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1350-9462(02)00063-0","article-title":"Role of the sclera in the development and pathological complications of myopia","volume":"22","author":"McBrien","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/cxo.12862","article-title":"Choroidal changes in human myopia: Insights from optical coherence tomography imaging","volume":"102","author":"Read","year":"2019","journal-title":"Clin. Exp. Optom."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"108332","DOI":"10.1016\/j.exer.2020.108332","article-title":"PPAR\u03b3 modulates refractive development and form deprivation myopia in Guinea pigs","volume":"202","author":"Pan","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.etp.2015.07.006","article-title":"Cytotoxicity of atropine to human corneal epithelial cells by inducing cell cycle arrest and mitochondrion-dependent apoptosis","volume":"67","author":"Tian","year":"2015","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Gan, J., Li, S.M., Wu, S., Cao, K., Ma, D., He, X., Hua, Z., Kang, M.T., Wei, S., and Bai, W. (2022). Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.756398"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Bucolo, C., Musumeci, M., Salomone, S., Romano, G.L., Leggio, G.M., Gagliano, C., Reibaldi, M., Avitabile, T., Uva, M.G., and Musumeci, S. (2015). Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate. Front. Pharmacol., 6.","DOI":"10.3389\/fphar.2015.00280"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.phrs.2008.02.002","article-title":"Effect of chitinase inhibitors on endotoxin-induced uveitis (EIU) in rabbits","volume":"57","author":"Bucolo","year":"2008","journal-title":"Pharmacol. Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/OPX.0000000000000129","article-title":"The effect of caffeine on tear secretion","volume":"91","author":"Osei","year":"2014","journal-title":"Optom. Vis. Sci."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"100138","DOI":"10.1016\/j.apjo.2025.100138","article-title":"Role of caffeine in slowing progression of myopia: 1-year results from a prospective, longitudinal clinical trial","volume":"14","author":"Tran","year":"2025","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1111\/bcp.15237","article-title":"The effect of systemic and topical ophthalmic medications on choroidal thickness: A review","volume":"88","author":"Yeung","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"969","DOI":"10.18240\/ijo.2023.06.21","article-title":"Role of 7-methylxanthine in myopia prevention and control: A mini-review","volume":"16","author":"Lai","year":"2023","journal-title":"Int. J. Ophthalmol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.preteyeres.2017.06.003","article-title":"Dopamine signaling and myopia development: What are the key challenges","volume":"61","author":"Zhou","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"300060519893866","DOI":"10.1177\/0300060519893866","article-title":"Protective effects of increased outdoor time against myopia: A review","volume":"48","author":"Zhang","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10792-024-03009-9","article-title":"Vitamin D and myopia: A review","volume":"44","author":"Yu","year":"2024","journal-title":"Int. Ophthalmol."},{"key":"ref_204","first-page":"416","article-title":"Ispol\u2019zovanie sinusoidal\u2019nogo modulirovannogo impul\u2019snogo toka dlia uluchsheniia akkomodatsionno\u012d sposobnosti glaz v komplekse lecheniia progressiruiushche\u012d shkol\u2019no\u012d blizorukosti [Use of a sinusoidal modulated pulsed current for improving ocular accommodation capacity in the combined treatment of progressive myopia in school-age children]","volume":"7","author":"Iakimchuk","year":"1988","journal-title":"Oftalmol Zh."},{"key":"ref_205","first-page":"24","article-title":"Transkon\u2019iunktival\u2019naia \u2018elektrooftal\u2019mostimuliatsiia v sisteme patogeneticheskogo lecheniia progressiruiushche\u00ed blizorukosti [Transconjunctival electrostimulation of eye in pathogenetic therapy of progressive myopia]","volume":"113","author":"Okovitov","year":"1997","journal-title":"Vestn Oftalmol."},{"key":"ref_206","first-page":"24","article-title":"Elektrostimuliatsiia i magnitoterapiia v lechenii spazma akkomodatsii i v profilaktike progressirovaniia miopii u dete\u012d i podrostkov [Electrostimulation and magnetic therapy in the treatment of accommodation cramp and in the prevention of progressive myopia in children and adolescents]","volume":"6","author":"Riabtseva","year":"2002","journal-title":"Med. Tekh."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1444-0938.2008.00256.x","article-title":"The eye in focus: Accommodation and presbyopia","volume":"91","author":"Charman","year":"2008","journal-title":"Clin. Exp. Optom."},{"key":"ref_208","first-page":"380","article-title":"Quantitative and morphometric studies of age-related changes in human ciliary muscle","volume":"36","author":"Nishida","year":"1992","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1474-9726.2007.00342.x","article-title":"Presbyopia and heat: Changes associated with aging of the human lens suggest a functional role for the small heat shock protein, alpha-crystallin, in maintaining lens flexibility","volume":"6","author":"Heys","year":"2007","journal-title":"Aging Cell"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3928\/1081597X-20170621-05","article-title":"Ciliary Muscle Electrostimulation to Restore Accommodation in Patients With Early Presbyopia: Preliminary Results","volume":"33","author":"Gualdi","year":"2017","journal-title":"J. Refract. Surg."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1096\/fj.00-0727fje","article-title":"Carnitine protects the molecular chaperone activity of lens alpha-crystallin and decreases the post-translational protein modifications induced by oxidative stress","volume":"15","author":"Peluso","year":"2001","journal-title":"FASEB J."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Gnoni, A., Longo, S., Gnoni, G.V., and Giudetti, A.M. (2020). Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?. Molecules, 25.","DOI":"10.3390\/molecules25010182"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41433-020-01391-z","article-title":"Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: A safety and preliminary efficacy trial","volume":"35","author":"Korenfeld","year":"2021","journal-title":"Eye"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"109992","DOI":"10.1016\/j.exer.2024.109992","article-title":"Effect of compound treatments on mouse lens viscoelasticity","volume":"246","author":"Mote","year":"2024","journal-title":"Exp. Eye Res."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Nakazawa, Y., Doki, Y., Sugiyama, Y., Kobayashi, R., Nagai, N., Morisita, N., Endo, S., Funakoshi-Tago, M., and Tamura, H. (2021). Effect of Alpha-Glucosyl-Hesperidin Consumption on Lens Sclerosis and Presbyopia. Cells, 10.","DOI":"10.3390\/cells10020382"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40123-016-0050-x","article-title":"Pharmacological Treatment of Presbyopia by Novel Binocularly Instilled Eye Drops: A Pilot Study","volume":"5","author":"Renna","year":"2016","journal-title":"Ophthalmol. Ther."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biopha.2013.07.001","article-title":"Iatrogenic dry eye disease: An eledoisin\/carnitine and osmolyte drops study","volume":"67","author":"Nebbioso","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Caballero-Garc\u00eda, A., Noriega-Gonz\u00e1lez, D.C., Roche, E., Drobnic, F., and C\u00f3rdova, A. (2023). Effects of L-Carnitine Intake on Exercise-Induced Muscle Damage and Oxidative Stress: A Narrative Scoping Review. Nutrients, 15.","DOI":"10.3390\/nu15112587"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Rusciano, D., and Bagnoli, P. (2025). Multimodality in the Collicular Pathway: Towards Compensatory Visual Processes. Cells, 14.","DOI":"10.3390\/cells14090635"},{"key":"ref_220","unstructured":"Lucchesi, M., Maya-Vetencourt, J.F., and Rusciano, D. (Front. Neurol., 2025). Multisensory Integration, Brain Plasticity and Optogenetics in Visual Rehabilitation, Front. Neurol., in press."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","article-title":"Partial recovery of visual function in a blind patient after optogenetic therapy","volume":"27","author":"Sahel","year":"2021","journal-title":"Nat. Med."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Skirzewski, M., Molotchnikoff, S., Hernandez, L.F., and Maya-Vetencourt, J.F. (2022). Multisensory Integration: Is Medial Prefrontal Cortex Signaling Relevant for the Treatment of Higher-Order Visual Dysfunctions?. Front. Mol. Neurosci., 14.","DOI":"10.3389\/fnmol.2021.806376"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Alwis, D.S., and Rajan, R. (2014). Environmental enrichment and the sensory brain: The role of enrichment in remediating brain injury. Front. Syst. Neurosci., 8.","DOI":"10.3389\/fnsys.2014.00156"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Proulx, C.E., Louis Jean, M.T., Higgins, J., Gagnon, D.H., and Dancause, N. (2022). Somesthetic, Visual, and Auditory Feedback and Their Interactions Applied to Upper Limb Neurorehabilitation Technology: A Narrative Review to Facilitate Contextualization of Knowledge. Front. Rehabil. Sci., 3.","DOI":"10.3389\/fresc.2022.789479"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"110638","DOI":"10.1016\/j.nanoen.2024.110638","article-title":"A visual-tactile synchronized stimulation ring system for sensory rehabilitation integrating triboelectric sensing and pneumatic feedback","volume":"135","author":"Yang","year":"2025","journal-title":"Nano Energy"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Rusciano, D. (2025). Light, Sound, and Melatonin: Investigating Multisensory Pathways for Visual Restoration. Medicina, 61.","DOI":"10.3390\/medicina61061009"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s11671-025-04234-6","article-title":"Ocular drug delivery systems based on nanotechnology: A comprehensive review for the treatment of eye diseases","volume":"20","author":"Bairagi","year":"2025","journal-title":"Discov. Nano"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Xu, K., Yu, L., Wang, Z., Lin, P., Zhang, N., Xing, Y., and Yang, N. (2023). Use of gene therapy for optic nerve protection: Current concepts. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1158030"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Sharif, N.A. (2021). Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.729249"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/DDDT.S515166","article-title":"Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions","volume":"19","author":"Chatzimichail","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"108192","DOI":"10.1016\/j.visres.2023.108192","article-title":"Genome editing, a superior therapy for inherited retinal diseases","volume":"206","author":"Yan","year":"2023","journal-title":"Vis. Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12967-024-05581-1","article-title":"Engineered sensor actuator modulator as aqueous humor outflow actuator for gene therapy of primary open-angle glaucoma","volume":"22","author":"Mohanty","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1177\/11206721231161101","article-title":"The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma","volume":"33","author":"Occhiutto","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"101218","DOI":"10.1016\/j.mam.2023.101218","article-title":"Gene therapies and gene product-based drug candidates for normalizing and preserving tissue functions in animal models of ocular hypertension and glaucoma","volume":"94","author":"Sharif","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/jop.2022.0046","article-title":"Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction","volume":"39","author":"Sharif","year":"2023","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/IIO.0000000000000541","article-title":"Glucagon-like Peptide-1 Receptor Agonists in the Management of Diabetic Retinopathy","volume":"65","author":"Samanta","year":"2025","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Xie, Z.J., Yuan, B.W., Chi, M.M., and Hong, J. (2024). Focus on seed cells: Stem cells in 3D bioprinting of corneal grafts. Front. Bioeng. Biotechnol., 12.","DOI":"10.3389\/fbioe.2024.1423864"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"100223","DOI":"10.1016\/j.cellin.2024.100223","article-title":"Progress in photoreceptor replacement therapy for retinal degenerative diseases","volume":"4","author":"Du","year":"2024","journal-title":"Cell Insight"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/stcltm\/szae005","article-title":"Recent Progress in Photoreceptor Cell-Based Therapy for Degenerative Retinal Disease","volume":"13","author":"Klymenko","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Pinto-Coelho, L. (2023). How Artificial Intelligence Is Shaping Medical Imaging Technology: A Survey of Innovations and Applications. Bioengineering, 10.","DOI":"10.20944\/preprints202311.1366.v1"},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Wu, K.Y., Mina, M., Carbonneau, M., Marchand, M., and Tran, S.D. (2023). Advancements in Wearable and Implantable Intraocular Pressure Biosensors for Ophthalmology: A Comprehensive Review. Micromachines, 14.","DOI":"10.3390\/mi14101915"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Pobo\u017cy, K., Pobo\u017cy, T., Doma\u0144ski, P., Derczy\u0144ski, M., Konarski, W., and Doma\u0144ska-Pobo\u017ca, J. (2025). Evolution of Light-Sensitive Proteins in Optogenetic Approaches for Vision Restoration: A Comprehensive Review. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020429"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Bordeau, C., Scalvini, F., Migniot, C., Dubois, J., and Ambard, M. (2025). Localization abilities with a visual-to-auditory substitution device are modulated by the spatial arrangement of the scene. Atten. Percept. Psychophys.","DOI":"10.3758\/s13414-025-03065-y"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2147\/OPTH.S513141","article-title":"From Monotherapy to Combination Strategies: Redefining Treatment Approaches for Multiple-Cause Macular Edema","volume":"19","author":"Zhu","year":"2025","journal-title":"Clin. Ophthalmol."},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Giansanti, D. (2025). Advancements in Ocular Neuro-Prosthetics: Bridging Neuroscience and Information and Communication Technology for Vision Restoration. Biology, 14.","DOI":"10.3390\/biology14020134"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/6\/883\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:51:02Z","timestamp":1760032262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/6\/883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":245,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ph18060883"],"URL":"https:\/\/doi.org\/10.3390\/ph18060883","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}